Net revenues

6 Months Ended

Jun. 28, 2020

Revenue from Contract with Customer [Abstract]

Net revenues

Net revenuesWe primarily generate revenue from the sale of medical devices including single use disposable devices and, to a lesser extent, reusable devices, instruments and capital equipment. Revenue is recognized when obligations under the terms of a contract with our customer are satisfied; this occurs upon the transfer of control of the products. Generally, transfer of control to the customer occurs at the point in time when our products are shipped from the manufacturing or distribution facility. For our Original Equipment and Development Services ("OEM") segment, most revenue is recognized over time because the OEM segment generates revenue from the sale of custom products that have no alternative use and we have an enforceable right to payment to the extent that performance has been completed. We market and sell products through our direct sales force and distributors to customers within the following end markets: (1) hospitals and healthcare providers; (2) other medical device manufacturers; and (3) home care providers such as pharmacies, which comprised 86%, 11% and 3% of consolidated net revenues, respectively, for the six months ended June 28, 2020. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods. With respect to the custom products sold in the OEM segment, revenue is measured using the units produced output method. Payment is generally due 30 days from the date of invoice.

The following table disaggregates revenue by global product category for the three and six months ended June 28, 2020 and June 30, 2019.

	Three Months Ended				Six Months Ended
	June 28, 2020		June 30, 2019		June 28, 2020		June 30, 2019
	(Dollars in thousands)
Vascular access	$	164,958	$	153,647	$	315,214	$	297,544
Anesthesia	64,867		85,723		140,569		165,975
Interventional	82,594		104,785		182,525		207,969
Surgical	67,275		95,570		142,707		182,289
Interventional urology	40,094		67,952		114,286		127,683
OEM	55,832		56,428		119,219		110,666
Other (1)	91,414		88,402		183,156		173,965
Net revenues (2)	$	567,034	$	652,507	$	1,197,676	$	1,266,091

(1) Revenues in the "Other" category in the table above include revenues generated from sales of our respiratory and urology products (other than interventional urology products).

(2) The product categories listed above are presented on a global basis, while each of our reportable segments other than the OEM reportable segment are defined based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the geographically based reportable segments include net revenues from each of the non-OEM product categories listed above.